MMR's hub-and-spoke PET-CT diagnostic chain — 90% revenue growth with 32% EBITDA margins
₹30 Cr revenue, 7 centres across Mumbai, now acquiring a 30-year Nashik brand. Radiology-heavy model in a ₹1,055B market where 98% of labs lack accreditation.
The business
Invicta operates 7 diagnostic centres + 1 centralized lab across Mumbai Metropolitan Region under the brand 'PC Diagnostics'. The hub-and-spoke model features PET-CT, MRI, CT scans at hub centres with sample collection spokes feeding into centralized labs. B2B (hospital referrals) + B2C (walk-ins). Now expanding beyond MMR via Vinchurkar Diagnostics acquisition in Nashik.
Why this business matters
India's ₹1,055B diagnostic market growing at 10.4% CAGR — 80-83% unorganized, only 2% of 1.08 lakh labs NABL-accredited. Massive consolidation opportunity for quality-focused organized chains
Radiology growing faster than pathology — 11.5% vs 9.7% CAGR. Invicta's radiology-heavy mix (PET-CT, MRI, CT) positions it in the higher-growth, higher-margin segment. PET-CT capability is rare among SME chains
Maharashtra diagnostic market at ₹3,550 Cr — largest state by NABL-accredited labs (292). Rising lifestyle diseases driving diagnostic demand. Healthcare exempt from GST
The moat
Reality check
Geographic concentration in MMR — all 7 centres within Mumbai metro. Any local competitive pressure or regulatory change impacts the entire business
Non-medical promoter majority — 3 of 5 promoters from finance, metals, and jewellery backgrounds. 37+ promoter group entities across unrelated sectors
Equipment replacement cycle approaching — PP&E net block declining. PET-CT replacement alone costs ₹15-25 Cr — potentially larger than one year's revenue
IPO objects changed within 4 months of listing — original plan for 5 centres revised to 4 + Vinchurkar acquisition. Rapid changes warrant monitoring
Exit Trigger
Exit if EBITDA margins drop below 25% for 2 consecutive quarters, if related party transactions with promoter group entities become material (>5% of revenue), or if Vinchurkar integration fails to contribute revenue within 2 quarters of acquisition
The verdict
Attractive growth story in a structurally growing sector — 90% revenue growth with 32% margins and strong cash conversion. The PET-CT capability and Vinchurkar acquisition show strategic ambition. However, the complex promoter structure, non-medical backgrounds, and short operating history make this a 'trust but verify' story requiring active monitoring.
Watch For
First post-acquisition quarter with Vinchurkar Diagnostics revenue contribution, new centre openings in Pune and Shegaon, EBITDA margin stabilization at 28-32%, and any changes in promoter group related party transactions.
Want the full story?
Read our comprehensive 7-chapter Deep Dive with financials, management analysis, IPO tracker, and more.
Read Full Deep DiveA PET-CT diagnostic chain growing 90% with 32% margins — in a market where 98% of labs lack accreditation. Quality consolidation play or governance concerns too high? Tell us below 👇
Share your view in the comments below
Disclaimer: For educational purposes only. Not SEBI-registered. Author may hold positions in stocks discussed. Not a buy/sell/hold recommendation. Do your own due diligence.
More SME in 6 Cards
Anlon Technology Solutions Ltd
India's only Make in India fire truck manufacturer with 7 exclusive global OEM partnerships
Sunita Tools Ltd
From mould bases to 155mm artillery shells — India's boldest SME defence pivot
Apsis Aerocom Ltd
This Bangalore micro-cap makes precision parts for global aerospace & defence OEMs
Shree Refrigerations Limited
India's only naval HVAC company with all 3 defence registrations — now entering data centre cooling
GSM Foils Ltd
₹258 Cr revenue in just 2 years — but where's the cash?
Prime Cable Industries Ltd
₹235 Cr revenue, ₹217 Cr order book — riding India's power infra boom
Supreme Power Equipment Ltd
₹578 Cr order book, 20% EBITDA margins — this transformer maker is scaling 8x
Digilogic Systems Limited
India's defence ATE specialist with AS9100D certification — EBITDA margins doubled to 18.6% in FY25
JD Cables Limited
From ₹41 Cr to ₹251 Cr in 2 years — 150% CAGR cable manufacturer now pivoting to ₹407 Cr EPC infrastructure
Kalyani Cast Tech Limited
IIT Madras founder builds India's import-substituting container maker — now eyeing ₹200 Cr wagon manufacturing bet
Nephro Care India Ltd
Nephrologist-founder builds East India's kidney care chain — now launching transplants and eyeing 300-clinic national footprint
Positron Energy Ltd
Three oil & gas veterans build India's asset-light gas aggregation platform — 39x revenue in 3 years with zero capex
S J Logistics (India) Ltd
From freight broker to vessel operator — 3.4x revenue in 2 years with expanding margins
TechEra Engineering (India) Ltd
Building the tools that build India's fighter jets — from Tejas to C-295 to Rafale
Telge Projects Limited
India's asset-light BIM engineering powerhouse with 33% EBITDA margins and 3.4x revenue growth in 2 years
Vigor Plast India Limited
The fittings-first PVC pipe brand earning 30% EBITDA margins where peers earn 12-15%
TBI Corn Limited
India's largest dry corn miller supplying ITC, Prataap Snacks & Balaji Wafers
MRP Agro Limited
Tikamgarh's dal mill story — ₹44 Cr → ₹104 Cr in one year, completely debt-free